Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Finasteride effectively improves hair growth in men with minimal side effects.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.

Both treatments for alopecia areata are equally effective and safe.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Baricitinib is effective and safe for treating alopecia areata.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.